BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11812214)

  • 21. Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro.
    Brummer E; Sugar AM; Stevens DA
    J Leukoc Biol; 1984 Oct; 36(4):505-20. PubMed ID: 6384406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement.
    Brummer E; Sugar AM; Stevens DA
    Infect Immun; 1983 Feb; 39(2):817-22. PubMed ID: 6832821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification in quantity of the secreted form of WI-1: a major adhesin on Blastomyces dermatitidis yeasts.
    Audet R; Brandhorst TT; Klein B
    Protein Expr Purif; 1997 Nov; 11(2):219-26. PubMed ID: 9367819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples.
    Burgess JW; Schwan WR; Volk TJ
    Med Mycol; 2006 Dec; 44(8):741-8. PubMed ID: 17127631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medium for susceptibility testing and yeast phase conversion of Blastomyces dermatitidis.
    Kurup VP; Resnick A; Rose HD
    Mycopathologia; 1986 Jul; 95(1):25-8. PubMed ID: 3762656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the in vitro and in vivo dimorphism of Sporothrix schenckii, Blastomyces dermatitidis, and Paracoccidioides brasiliensis isolates after preservation in mineral oil.
    Lima RF; Santos Brito MM; Schäffer GM; Lima OC; Borba Cde M
    Can J Microbiol; 2004 Jun; 50(6):445-9. PubMed ID: 15284890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular growth and phagocytosis of Blastomyces dermatitidis by monocyte-derived macrophages from previously infected and normal subjects.
    Bradsher RW; Ulmer WC; Marmer DJ; Townsend JW; Jacobs RF
    J Infect Dis; 1985 Jan; 151(1):57-64. PubMed ID: 3965594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence.
    Krajaejun T; Wüthrich M; Gauthier GM; Warner TF; Sullivan TD; Klein BS
    Infect Immun; 2010 Jun; 78(6):2522-8. PubMed ID: 20368350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the molecular ecology of Blastomyces dermatitidis.
    Baumgardner DJ; Laundre B
    Mycopathologia; 2001; 152(2):51-8. PubMed ID: 11761145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and detection of cell-mediated reactions with different Blastomyces dermatitidis antigenic preparations.
    Abuodeh RO; Winston V; Scalarone GM
    Mycoses; 1996; 39(3-4):85-93. PubMed ID: 8766999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastomyces dermatitidis yeast cells inhibit nitric oxide production by alveolar macrophage inducible nitric oxide synthase.
    Rocco NM; Carmen JC; Klein BS
    Infect Immun; 2011 Jun; 79(6):2385-95. PubMed ID: 21444664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Iron and infection. II. Outline of the normal dynamics of iron in the human body and characteristic changes induced by infection in iron metabolism. Iron-transporting proteins with a role in defense against infection in humans].
    Dragomirescu T; Antonescu M; Apăteanu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1979; 24(4):193-206. PubMed ID: 119294
    [No Abstract]   [Full Text] [Related]  

  • 33. Interactions between human granulocytes and Blastomyces dermatitidis.
    Sixbey JW; Fields BT; Sun CN; Clark RA; Nolan CM
    Infect Immun; 1979 Jan; 23(1):41-4. PubMed ID: 422234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous mutant of Blastomyces dermatitidis attenuated in virulence for mice.
    Brass C; Volkmann CM; Philpott DE; Klein HP; Halde CJ; Stevens DA
    Sabouraudia; 1982 Jun; 20(2):145-58. PubMed ID: 7112336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of culture filtrates of Blastomyces dermatitidis on neutrophil locomotion.
    Mitchell TG; Turner SR
    Sabouraudia; 1984; 22(2):145-53. PubMed ID: 6374935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological conversion of Blastomyces dermatitidis in tap-water.
    Sheiban ZB
    Bull World Health Organ; 1974; 51(4):423-7. PubMed ID: 4549493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and -independent mechanisms.
    Finkel-Jimenez B; Wüthrich M; Klein BS
    J Immunol; 2002 Jun; 168(11):5746-55. PubMed ID: 12023375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cultural and histopathologic confirmation of canine blastomycosis diagnosed by an agar-gel immunodiffusion test.
    Phillips WE; Kaufman L
    Am J Vet Res; 1980 Aug; 41(8):1263-5. PubMed ID: 6778271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of IL-6, in contrast to other cytokines and chemokines, in macrophage innate immune responses: effect of serum and fungal (Blastomyces) challenge.
    Brummer E; Capilla J; Bythadka L; Stevens DA
    Cytokine; 2007 Sep; 39(3):163-70. PubMed ID: 17716906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence elements necessary for transcriptional activation of BAD1 in the yeast phase of Blastomyces dermatitidis.
    Rooney PJ; Klein BS
    Eukaryot Cell; 2004 Jun; 3(3):785-94. PubMed ID: 15189999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.